HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhuo Wang Selected Research

efatutazone

1/2018Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
12/2017PPARĪ³ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARĪ³/PTEN/Akt pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhuo Wang Research Topics

Disease

128Neoplasms (Cancer)
12/2022 - 08/2002
19Infections
01/2022 - 03/2004
18Inflammation (Inflammations)
06/2022 - 07/2012
18Neoplasm Metastasis (Metastasis)
11/2021 - 10/2005
17Breast Neoplasms (Breast Cancer)
01/2022 - 05/2002
17Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 11/2013
16Carcinogenesis
01/2022 - 05/2002
14Hypertension (High Blood Pressure)
11/2022 - 11/2013
13Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2014
13Fibrosis (Cirrhosis)
01/2022 - 02/2002
12Stroke (Strokes)
11/2022 - 02/2017
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 01/2014
11Lung Neoplasms (Lung Cancer)
01/2022 - 01/2016
10Alzheimer Disease (Alzheimer's Disease)
07/2021 - 01/2012
9Leukemia
07/2013 - 10/2009
8Atrial Fibrillation
01/2022 - 11/2014
8Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2019
8Ischemia
10/2021 - 02/2008
8Myocardial Infarction
01/2021 - 11/2014
8Osteosarcoma (Osteogenic Sarcoma)
09/2020 - 09/2012
7Cognitive Dysfunction
12/2022 - 06/2011
7Carcinoma (Carcinomatosis)
01/2022 - 10/2011
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2015
7Hypoxia (Hypoxemia)
01/2021 - 07/2013
6Prostatic Neoplasms (Prostate Cancer)
04/2022 - 10/2009
6Adenocarcinoma of Lung
01/2022 - 06/2016
6Heart Failure
01/2021 - 12/2014
5Ischemic Stroke
07/2022 - 06/2019
5Pneumonia (Pneumonitis)
01/2022 - 12/2016
5Wounds and Injuries (Trauma)
01/2022 - 01/2011
5Pain (Aches)
01/2021 - 09/2009
4Liver Neoplasms (Liver Cancer)
01/2022 - 01/2017
4Brain Ischemia (Cerebral Ischemia)
01/2022 - 02/2008
4Reperfusion Injury
01/2022 - 05/2008
4Schizophrenia (Dementia Praecox)
01/2022 - 01/2017
4Virus Diseases (Viral Diseases)
12/2021 - 03/2014
4Circulating Neoplastic Cells
01/2021 - 01/2019
4Body Weight (Weight, Body)
01/2021 - 01/2015
4HIV Infections (HIV Infection)
01/2021 - 01/2017
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2020 - 02/2008
4Colonic Neoplasms (Colon Cancer)
10/2020 - 03/2017
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 01/2015
4Cardiac Arrhythmias (Arrythmia)
01/2019 - 01/2015
4Liver Cirrhosis (Hepatic Cirrhosis)
12/2018 - 02/2002
3Starvation
08/2022 - 02/2012
3Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022 - 08/2021
3Type 2 Diabetes Mellitus (MODY)
02/2022 - 03/2021

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2006
22Pharmaceutical PreparationsIBA
03/2022 - 08/2008
16RNA (Ribonucleic Acid)IBA
09/2022 - 09/2012
16Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2013
15Long Noncoding RNAIBA
05/2022 - 01/2016
13Biological ProductsIBA
01/2022 - 02/2012
12Glucose (Dextrose)FDA LinkGeneric
08/2022 - 02/2008
12MicroRNAs (MicroRNA)IBA
05/2022 - 01/2015
12Messenger RNA (mRNA)IBA
01/2022 - 07/2006
12Protein Glutamine gamma Glutamyltransferase 2IBA
02/2021 - 10/2011
11Peptides (Polypeptides)IBA
02/2022 - 01/2013
8CytokinesIBA
10/2022 - 05/2007
8Therapeutic UsesIBA
06/2022 - 02/2017
8CollagenIBA
11/2021 - 06/2009
7Small Interfering RNA (siRNA)IBA
01/2022 - 12/2010
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2009
7LipidsIBA
01/2018 - 09/2011
6Amyloid (Amyloid Fibrils)IBA
12/2022 - 01/2018
6EnzymesIBA
01/2021 - 04/2012
6Doxorubicin (Adriamycin)FDA LinkGeneric
09/2020 - 10/2008
6ErbB Receptors (EGF Receptor)IBA
05/2018 - 01/2014
6Telomerase (Telomerase Reverse Transcriptase)IBA
09/2013 - 05/2002
5Blood Glucose (Blood Sugar)IBA
11/2022 - 02/2013
5Insulin (Novolin)FDA Link
06/2022 - 01/2015
5LigandsIBA
01/2022 - 05/2013
5CateninsIBA
06/2021 - 01/2016
5Gefitinib (Iressa)FDA Link
01/2021 - 02/2017
4hydroxide ionIBA
11/2022 - 08/2019
4Sirtuin 1IBA
10/2022 - 01/2021
4CopperIBA
08/2022 - 01/2018
4Antiviral Agents (Antivirals)IBA
01/2022 - 01/2017
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2018
4HexokinaseIBA
01/2022 - 12/2020
4VaccinesIBA
01/2022 - 03/2003
4AntioxidantsIBA
01/2022 - 01/2015
4ChemokinesIBA
01/2022 - 01/2017
4Tyrosine Kinase InhibitorsIBA
01/2021 - 06/2016
4Competitive Endogenous RNAIBA
01/2021 - 01/2019
4Epidermal Growth Factor (EGF)IBA
01/2020 - 07/2006
4CholesterolIBA
09/2019 - 02/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 03/2008
4AntigensIBA
01/2019 - 09/2012
3interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA
12/2022 - 01/2020
3Vitamin DFDA LinkGeneric
11/2022 - 12/2020
3Interleukin-6 (Interleukin 6)IBA
10/2022 - 05/2006
3Glutathione (Reduced Glutathione)IBA
08/2022 - 09/2020
3ManganeseIBA
05/2022 - 01/2022

Therapy/Procedure

47Therapeutics
12/2022 - 05/2002
28Drug Therapy (Chemotherapy)
04/2022 - 05/2005
8Vagus Nerve Stimulation
02/2016 - 11/2014
6Immunotherapy
01/2022 - 03/2014
5Hematopoietic Stem Cell Transplantation
04/2022 - 01/2021
3Photothermal Therapy
08/2022 - 01/2019